Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Arbor Pharmaceuticals, Inc.

Home Clinical Trial Sponsors and OrganizationsArbor Pharmaceuticals, Inc.

Arbor Pharmaceuticals, Inc.

ACTIVE

6 Concourse Pkwy Ste 1800, Atlanta, 佐治亚州, United StatesSubsidiary

Also known as:

arbor pharmaceuticals

Part of Arbor Pharmaceuticals LLC

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

15

0 active

Approvals

14

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

26.7%

Phase 3

4

26.7%

Phase 2

3

20.0%

Phase 4

3

20.0%

Trial Status Distribution

Completed

12

80.0%

Terminated

3

20.0%

Clinical Trials

Trials sponsored by this organization (15)

Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users

Jan 2022110 participants

An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users

Sep 202186 participants

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

Sep 2018320 participants

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

Apr 2016272 participants

Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets

Sep 201512 participants

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Mar 2015377 participants

Relative Bioavailability of AR10 Compared to Reference Product

Apr 201430 participants

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Jan 201432 participants

Page 1 of 2

Approvals

Approvals by Agency

FDA

Food and Drug Administration

14

Approvals

Recent Approvals

Erythrocin Stearate

Erythrocin Stearate

News

No news articles found

On this page

Overview
Clinical Trials15
Approvals14
News

Back to Organizations